Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunological studies on sporamycin-treated animals.

K Komiyama, I Umezawa, T Akiyama

    The Journal of Antibiotics
    |November 1, 1979
    PubMed
    Summary

    Sporamycin demonstrated significant tumor regression in sarcoma-180. Immunological studies revealed enhanced immune responses, including macrophage migration inhibition and delayed hypersensitivity, in treated mice, suggesting potent anti-cancer activity.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Rocuronium priming for tracheal intubation in COVID-19 patients.

    Anaesthesia reports·2020
    Same author

    Denture wearing during sleep doubles the risk of pneumonia in the very elderly.

    Journal of dental research·2014
    Same author

    Antitumour antibiotics and their producing microorganisms.

    World journal of microbiology & biotechnology·2014
    Same author

    Distinct functional regions of the human polymeric immunoglobulin receptor.

    Scandinavian journal of immunology·2013
    Same author

    Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601).

    British journal of cancer·2012
    Same author

    The use of arthrography in the diagnosis of temporomandibular joint synovial chondromatosis.

    Dento maxillo facial radiology·2012

    Area of Science:

    • Immunology
    • Pharmacology
    • Oncology

    Background:

    • Sarcoma-180 is a common murine tumor model.
    • Understanding the immunological mechanisms of anti-cancer agents is crucial for effective treatment.

    Purpose of the Study:

    • To investigate the immunological effects of sporamycin on sarcoma-180 tumor-bearing mice.
    • To evaluate the anti-tumor activity and immune response modulation by sporamycin.

    Main Methods:

    • Assessing macrophage migration inhibition using spleen cells from treated mice.
    • Evaluating delayed hypersensitivity via foot-pad reactions.
    • Testing tumor growth inhibition by co-inoculating tumor cells with spleen cells from treated mice.
    • Examining the synergistic effect of sporamycin combined with PS-K (an immunopotentiator).

    Main Results:

    • Sporamycin treatment led to positive macrophage migration inhibition and delayed hypersensitivity responses.
    • Spleen cells from sporamycin-treated mice significantly inhibited sarcoma-180 tumor growth in normal mice.
    • Combined treatment with sporamycin and PS-K exhibited a remarkable synergistic anti-tumor effect.

    Conclusions:

    • Sporamycin exhibits potent anti-tumor activity against sarcoma-180, mediated by immunological mechanisms.
    • The drug enhances cellular immune responses, including macrophage and T-cell mediated immunity.
    • Sporamycin holds promise as an anti-cancer therapeutic, potentially enhanced by immunopotentiators.

    Related Experiment Videos